Mithila Samachar

Osteoarthritis Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies – Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics

 Breaking News
  • No posts were found

Osteoarthritis Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies – Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics

January 20
16:33 2023
Osteoarthritis Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies - Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics
The Osteoarthritis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteoarthritis pipeline products will significantly revolutionize the Osteoarthritis market dynamics.

DelveInsight’s “Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Osteoarthritis, historical and forecasted epidemiology as well as the Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Osteoarthritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Osteoarthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Osteoarthritis Market Insights

 

Osteoarthritis Overview

Osteoarthritis (OA), also known as degenerative joint disease (DJD), is the most common type of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of the bones wears down over time. Although osteoarthritis can damage any joint in the body, the disorder most commonly affects joints in hands, knees, hips and spine, and is more likely to develop as people age although it can occur in adults of any age.

 

Some of the key facts of the Osteoarthritis Market Report: 

  • The Osteoarthritis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • The Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study in Japan conducted by Yoshimura, showed a significant rise in knee OA through working age. As per this study, in Japan, OA affects approximately 25.3 million individuals aged over 40 years
  • The study by Swain et al., aimed to explore the incidence and prevalence of OA in the UK in 2017 and their trends using the UK Clinical Practice Research Data link (CPRD) comprising data on nearly 17.5 million patients
  • Key Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, and others
  • Key Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin, RTX-GRT7039, Lorecivivint, X0002, Amniofix, Ampion, ReNu, Cartistem, JointStem, and others

 

Get a Free sample for the Osteoarthritis Market Report –

https://www.delveinsight.com/sample-request/osteoarthritis-market

 

Key benefits of the Osteoarthritis Market report:

  1. Osteoarthritis market report covers a descriptive overview and comprehensive insight of the Osteoarthritis Epidemiology and Osteoarthritis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Osteoarthritis market report provides insights on the current and emerging therapies.
  3. Osteoarthritis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Osteoarthritis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Osteoarthritis market.

 

Download the report to understand which factors are driving Osteoarthritis epidemiology trends @ Osteoarthritis Epidemiological Insights 

 

Osteoarthritis Market  

The dynamics of the Osteoarthritis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“According to the estimates, the highest market size of OA was found in the United States and the least was in Italy across the 7MM. Besides, the upcoming therapies of OA are expected to combat the current unmet needs faced by the patients with OA and add to the overall growth of the OA market size.”

 

Osteoarthritis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Osteoarthritis Epidemiology Segmentation:

The Osteoarthritis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Osteoarthritis
  • Prevalent Cases of Osteoarthritis by severity
  • Gender-specific Prevalence of Osteoarthritis
  • Diagnosed Cases of Episodic and Chronic Osteoarthritis

 

Osteoarthritis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Osteoarthritis market or expected to get launched during the study period. The analysis covers Osteoarthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Osteoarthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Osteoarthritis market share @ Osteoarthritis market forecast 

 

Osteoarthritis Therapies and Key Companies

  • CNTX-4975: Centrexion Therapeutics
  • TLC599: Taiwan Liposome Company
  • Resiniferatoxin/RTX-GRT7039: Grünenthal
  • Lorecivivint: Biosplice Therapeutics
  • X0002: Techfields
  • Amniofix: MiMedx
  • Ampion: Ampio Pharmaceuticals
  • ReNu: Organogenesis
  • Cartistem: Medipost
  • JointStem: Naturecell

 

Osteoarthritis Market Strengths

  • Now companies are investing heavily in developing disease modifying therapies for the treatment of Osteoarthritis which will fulfill a major unmet need
  • Single injection joint function enhancing hyaluronic acid formulation’s sales are steadily rising, and companies are looking to expand into new markets in order to increase their profit of their single injection products

 

Scope of the Osteoarthritis Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Osteoarthritis Companies: Centrexion Therapeutics, Taiwan Liposome Company, Grünenthal, Biosplice Therapeutics, Techfields, MiMedx, Ampio Pharmaceuticals, Organogenesis, Medipost, Naturecell, and others
  • Key Osteoarthritis Therapies: CNTX-4975, TLC599, Resiniferatoxin, RTX-GRT7039, Lorecivivint, X0002, Amniofix, Ampion, ReNu, Cartistem, JointStem, and others
  • Osteoarthritis Therapeutic Assessment: Osteoarthritis current marketed and Osteoarthritis emerging therapies
  • Osteoarthritis Market Dynamics: Osteoarthritis market drivers and Osteoarthritis market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Osteoarthritis Unmet Needs, KOL’s views, Analyst’s views, Osteoarthritis Market Access and Reimbursement 

 

Osteoarthritis Market Opportunities

  • Lucrative opportunities in nations where single-injection joint function enhancing drugs are unavailable. The growth of the Osteoarthritis market is driven by an increase in the geriatric population and obesity

 

Table of Contents 

1. Osteoarthritis Market Report Introduction

2. Executive Summary for Osteoarthritis

3. SWOT analysis of Osteoarthritis

4. Osteoarthritis Patient Share (%) Overview at a Glance

5. Osteoarthritis Market Overview at a Glance

6. Osteoarthritis Disease Background and Overview

7. Osteoarthritis Epidemiology and Patient Population

8. Country-Specific Patient Population of Osteoarthritis 

9. Osteoarthritis Current Treatment and Medical Practices

10. Osteoarthritis Unmet Needs

11. Osteoarthritis Emerging Therapies

12. Osteoarthritis Market Outlook

13. Country-Wise Osteoarthritis Market Analysis (2019–2032)

14. Osteoarthritis Market Access and Reimbursement of Therapies

15. Osteoarthritis Market Drivers

16. Osteoarthritis Market Barriers

17.  Osteoarthritis Appendix

18. Osteoarthritis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Osteoarthritis treatment, visit @ Osteoarthritis Medications 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting